The frequency and skewed T-cell receptor beta-chain variable patterns of peripheral CD4+CD25+ regulatory T-cells are associated with hepatitis B e antigen seroconversion of chronic hepatitis B patients during antiviral treatment (original) (raw)

• McMahon BJ . The natural history of chronic hepatitis B virus infection. Hepatology 2009; 49: S45–55 .
  Article CAS Google Scholar
• Lanini S, Puro V, Lauria FN, Fusco FM, Nisii C, Ippolito G . Patient to patient transmission of hepatitis B virus: a systematic review of reports on outbreaks between 1992 and 2007. BMC Med 2009; 7: 15 .
  Article Google Scholar
• Liaw YF . Impact of therapy on the outcome of chronic hepatitis B. Liver Int 2013; 33 Suppl 1:111–115 .
  Article CAS Google Scholar
• Baran B, Soyer OM, Ormeci AC, Gokturk S, Evirgen S, Akyuz F et al. Tenofovir disoproxil fumarate has a substantial efficacy against multidrug resistant strains of hepatitis b virus. Liver Int 2015; 35: 2265–2274 .
  Article CAS Google Scholar
• Snow-Lampart A, Chappell B, Curtis M, Zhu Y, Myrick F, Schawalder J et al. No resistance to tenofovir disoproxil fumarate detected after up to 144 weeks of therapy in patients monoinfected with chronic hepatitis B virus. Hepatology 2011; 53: 763–773 .
  Article CAS Google Scholar
• Hung CH, Hu TH, Lu SN, Lee CM, Chen CH, Kee KM et al. Tenofovir versus entecavir in the treatment of chronic hepatitis B with severe acute exacerbation. Antimicrob Agents Chemother 2015; 59: 3168–3173 .
• Boni C, Laccabue D, Lampertico P, Giuberti T, Vigano M, Schivazappa S et al. Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues. Gastroenterology 2012; 143: 963–973.e9 .
  Article CAS Google Scholar
• Stoop JN, Claassen MA, Woltman AM, Binda RS, Kuipers EJ, Janssen HL et al. Intrahepatic regulatory T cells are phenotypically distinct from their peripheral counterparts in chronic HBV patients. Clin Immunol 2008; 129: 419–427 .
  Article CAS Google Scholar
• Stoop JN, van der Molen RG, Kuipers EJ, Kusters JG, Janssen HL . Inhibition of viral replication reduces regulatory T cells and enhances the antiviral immune response in chronic hepatitis B. Virology 2007; 361: 141–148 .
  Article CAS Google Scholar
• Yan Z, Zhou J, Zhang M, Fu X, Wu Y, Wang Y . Telbivudine decreases proportion of peripheral blood CD4+CD25+CD127 low T cells in parallel with inhibiting hepatitis B virus DNA. Mol Med Rep 2014; 9: 2024–2030 .
  Article CAS Google Scholar
• TrehanPati N, Kotillil S, Hissar SS, Shrivastava S, Khanam A, Sukriti S et al. Circulating Tregs correlate with viral load reduction in chronic HBV-treated patients with tenofovir disoproxil fumarate. J Clin Immunol 2011; 31: 509–520 .
  Article CAS Google Scholar
• Xu D, Fu J, Jin L, Zhang H, Zhou C, Zou Z et al. Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B. J Immunol 2006; 177: 739–747 .
  Article CAS Google Scholar
• Attaf M, Huseby E, Sewell AK . Alphabeta T cell receptors as predictors of health and disease. Cell Mol Immunol 2015; 12: 391–399 .
  Article CAS Google Scholar
• Nikolich-Zugich J, Slifka MK, Messaoudi I . The many important facets of T-cell repertoire diversity. Nat Rev Immunol 2004; 4: 123–132 .
  Article CAS Google Scholar
• Turner SJ, Doherty PC, McCluskey J, Rossjohn J . Structural determinants of T-cell receptor bias in immunity. Nat Rev Immunol 2006; 6: 883–894 .
  Article CAS Google Scholar
• Yin Y, Li Y, Mariuzza RA . Structural basis for self-recognition by autoimmune T-cell receptors. Immunol Rev 2012; 250: 32–48 .
  Article Google Scholar
• Yang J, Yi P, Wei L, Xu Z, Chen Y, Tang L et al. Phenotypes and clinical significance of circulating CD4(+)CD25(+) regulatory T cells (Tregs) in patients with acute-on-chronic liver failure (ACLF). J Transl Med 2012; 10: 193 .
  Article CAS Google Scholar
• Heathcote EJ, Marcellin P, Buti M, Gane E, De Man RA, Krastev Z et al. Three-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B. Gastroenterology 2011; 140: 132–143 .
  Article CAS Google Scholar
• Yang J, Chen J, Ye P, Jin L, Wu W, Sheng G et al. HBsAg as an important predictor of HBeAg seroconversion following antiviral treatment for HBeAg-positive chronic hepatitis B patients. J Transl Med 2014; 12: 183 .
  Article Google Scholar
• Lai CL, Ahn SH, Lee KS, Um SH, Cho M, Yoon SK et al. Phase IIb multicentred randomised trial of besifovir (LB80380) versus entecavir in Asian patients with chronic hepatitis B. Gut 2014; 63: 996–1004 .
  Article Google Scholar
• Yang J, Chen J, He J, Xie Y, Zhu Y, Cao H et al. Profiling the repertoire of T-cell receptor beta-chain variable genes in peripheral blood lymphocytes from subjects who have recovered from acute hepatitis B virus infection. Cell Mol Immunol 2014; 11: 343–354 .
  Article Google Scholar
• Yang J, Xu K, Zheng J, Wei L, Fan J, Li L . Limited T cell receptor beta variable repertoire responses to ESAT-6 and CFP-10 in subjects infected with Mycobacterium tuberculosis. Tuberculosis (Edinb) 2013; 93: 529–537 .
  Article Google Scholar
• Yang J, Chen J, Mao H, Yi P, Yan D, He J et al. Skewed T-cell receptor beta chain variable gene (TCRBV) usage among different clinical types of patients with chronic HBV infection. FEMS Immunol Med Microbiol 2012; 65: 448–455 .
  Article CAS Google Scholar
• Schwanninger A, Weinberger B, Weiskopf D, Herndler-Brandstetter D, Reitinger S, Gassner C et al. Age-related appearance of a CMV-specific high-avidity CD8+ T cell clonotype which does not occur in young adults. Immun Ageing 2008; 5: 14 .
  Article Google Scholar
• Peng G, Li S, Wu W, Tan X, Chen Y, Chen Z . PD-1 upregulation is associated with HBV-specific T cell dysfunction in chronic hepatitis B patients. Mol Immunol 2008; 45: 963–970 .
  Article CAS Google Scholar
• Buti M, Homs M . Tenofovir disoproxil fumarate in the treatment of chronic hepatitis B. Expert Rev Gastroenterol Hepatol 2012; 6: 413–421 .
  Article CAS Google Scholar
• Baran B, Soyer OM, Ormeci AC, Gokturk S, Evirgen S, Bozbey HU et al. Efficacy of tenofovir in patients with Lamivudine failure is not different from that in nucleoside/nucleotide analogue-naive patients with chronic hepatitis B. Antimicrob Agents Chemother 2013; 57: 1790–1796 .
  Article CAS Google Scholar
• Martinet J, Leroy V, Dufeu-Duchesne T, Larrat S, Richard MJ, Zoulim F et al. Plasmacytoid dendritic cells induce efficient stimulation of antiviral immunity in the context of chronic hepatitis B virus infection. Hepatology 2012; 56: 1706–1718 .
  Article CAS Google Scholar
• Belkaid Y, Rouse BT . Natural regulatory T cells in infectious disease. Nat Immunol 2005; 6: 353–360 .
  Article CAS Google Scholar
• Ma H, Zhang HH, Wei L . Frequency of T-cell FoxP3(+) Treg and CD4(+)/CD8(+) PD-1 expression is related to HBeAg seroconversion in hepatitis B patients on pegylated interferon. Chin Med J 2013; 126: 267–273 .
  CAS PubMed Google Scholar
• Fried MW, Piratvisuth T, Lau GK, Marcellin P, Chow WC, Cooksley G et al. HBeAg and hepatitis B virus DNA as outcome predictors during therapy with peginterferon alfa-2a for HBeAg-positive chronic hepatitis B. Hepatology 2008; 47: 428–434 .
  Article CAS Google Scholar
• Seto WK, Liu K, Wong DK, Fung J, Huang FY, Hung IF et al. Patterns of hepatitis B surface antigen decline and HBV DNA suppression in Asian treatment-experienced chronic hepatitis B patients after three years of tenofovir treatment. J Hepatol 2013; 59: 709–716 .
  Article CAS Google Scholar
• Janssen HL, van Zonneveld M, Senturk H, Zeuzem S, Akarca US, Cakaloglu Y et al. Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial. Lancet 2005; 365: 123–129 .
  Article CAS Google Scholar
• Reijnders JG, Rijckborst V, Sonneveld MJ, Scherbeijn SM, Boucher CA, Hansen BE et al. Kinetics of hepatitis B surface antigen differ between treatment with peginterferon and entecavir. J Hepatol 2011; 54: 449–454 .
  Article CAS Google Scholar
• Sainz-Perez A, Lim A, Lemercier B, Leclerc C . The T-cell receptor repertoire of tumor-infiltrating regulatory T lymphocytes is skewed toward public sequences. Cancer Res 2012; 72: 3557–3569 .
  Article CAS Google Scholar
• Duan F, Duitama J, Al Seesi S, Ayres CM, Corcelli SA, Pawashe AP et al. Genomic and bioinformatic profiling of mutational neoepitopes reveals new rules to predict anticancer immunogenicity. J Exp Med 2014; 211: 2231–2248 .
  Article Google Scholar
• Vonderheide RH, June CH . Engineering T cells for cancer: our synthetic future. Immunol Rev 2014; 257: 7–13 .
  Article CAS Google Scholar
• Cuende J, Lienart S, Dedobbeleer O, van der Woning B, De Boeck G, Stockis J et al. Monoclonal antibodies against GARP/TGF-beta1 complexes inhibit the immunosuppressive activity of human regulatory T cells in vivo. Sci Transl Med 2015; 7: 284ra256 .
  Article Google Scholar
• Tang H, Qiao J, Fu YX . Immunotherapy and tumor microenvironment. Cancer Lett 2016; 370: 85–90
  Article CAS Google Scholar
• Qasim W, Thrasher AJ . Progress and prospects for engineered T cell therapies. Br J Haematol 2014; 166: 818–829 .
  Article CAS Google Scholar
• Petersen J, Montserrat V, Mujico JR, Loh KL, Beringer DX, van Lummel M et al. T-cell receptor recognition of HLA-DQ2-gliadin complexes associated with celiac disease. Nat Struct Mol Biol 2014; 21: 480–488 .
  Article CAS Google Scholar
• Miles JJ, Douek DC, Price DA . Bias in the alphabeta T-cell repertoire: implications for disease pathogenesis and vaccination. Immunol Cell Biol 2011; 89: 375–387 .
  Article CAS Google Scholar
• Baecher-Allan C, Wolf E, Hafler DA . Functional analysis of highly defined, FACS-isolated populations of human regulatory CD4+ CD25+ T cells. Clin Immunol 2005; 115: 10–18 .
  Article CAS Google Scholar
• Li Z, Li D, Tsun A, Li B . FOXP3(+) regulatory T cells and their functional regulation. Cell Mol Immunol 2015; 12: 558–565 .
  Article Google Scholar